US 10201516
Targeting K-Ras-mediated signaling pathways and malignancy by prostratin
granted A61KA61K31/22A61K31/25
Quick answer
US patent 10201516 (Targeting K-Ras-mediated signaling pathways and malignancy by prostratin) held by The Regents of the University of California expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/22, A61K31/25, A61K31/7068, A61K45/06